medigraphic.com
Boletín Clínico de la Asociación Médica del Hospital Infantil del Estado de Sonora

2024, Number 1

<< Back Next >>

Bol Clin Hosp Infant Edo Son 2024; 41 (1)

Alveolar proteinosis. Case Report

Torres GIG, Pérez MGD, Cano RMA, Romo DKJ, Barraza LAR, Castillo AJD

Language: Spanish
References: 20
Page: 59-63
PDF size: 168.99 Kb.


ABSTRACT

Alveolar proteinosis syndrome is a disease caused by a dysfunction of granulocyte-monocyte colony-stimulating factor (GM-CSF), resulting in a poor clearance of alveolar surfactant fluid. It can be classified in three types: primary / autoimmune representing the 90% of the cases, secondary and, congenital described mostly in pediatric patients. A female scholar patient of 8 years old is presented, with a tracheostomy tube and chronic supplementary oxygen needs had an abrupt presentation of abundant blood secretions. A chest CT-scan showed multiple heterogeneous hyperdense images, both in the periphery and basal region in the left lung, which led to a lung biopsy identifying alveolar proteinosis. This case report is an unspecific and rare clinic presentation of alveolar proteinosis syndrome in a pediatric patient.


REFERENCES

  1. Stéphane J, Cédric M, Mathieu L. Pulmonary AlveolarProteinosis. APSR Wiley [Internet]. 2020 [consultado 22 Dic 2023]; 25(8): 771-904. Disponible en:https://onlinelibrary.wiley.com/doi/epdf/10.1111/resp.13597

  2. Alan K, Cormac M. Pulmonary Alveolar ProteinosisSyndrome. Respir Crit Care Med [Internet]. 2020[consultado 22 Dic 2023]; 41(2): 288-298. Disponibleen: https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0039-3402727

  3. Francesco B, Peer C, Matthias G, Shinichiro O, JosuneG, Ulrich C. Pulmonary alveolar proteinosis: newinsights from a single-center cohort of 70 patients.Resp Med [Internet]. 2011 [consultado 27 Dic 2023];105(12): 1908-1916. Disponible en: https://www.resmedjournal.com/article/S0954-6111(11)00295-2/fulltext

  4. John F, Jeffrey J. Pulmonary alveolar proteinosis:progress in the first 44 years. AJRCMB [Internet].2002 [consultado 02 Ene 2024]; 166(2): 215-235. Disponible en: https://www.atsjournals.org/doi/10.1164/rccm.2109105

  5. Borie R, Danel C, Debray P, Taille C, Dombret M, AubierM, et al. Pulmonary alveolar proteinosis. EurResp Rev Jour [Internet]. 2011 [consultado 02 Ene2024]; 20(120): 98-107. Disponible en: https://err.ersjournals.com/content/20/120/98

  6. Mari T, Koji S, Satoshi M, Masakatsu Y, TsubasaO, Noriko M, et al. Hematopoietic stem cell transplantationfor pulmonary alveolar proteinosis associatedwith primary immunodeficiency disease.Int Jour of hem [Internet]. 2018 [consultado 03 Ene2024]; 107(5): 610-614. Disponible en: https://link.springer.com/article/10.1007/s12185-017-2375-1

  7. Hee-young Y, Ji H, Ye-Jee K, Jin W. Pulmonary alveolarproteinosis in Korea: analysis of prevalenceand incidence via a nationwide population-basedstudy. BMC Pub [Internet]. 2020 [consultado 04Ene 2024]; 20(34): 1-8. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006195/pdf/12890_2020_Article_1074.pdf

  8. Joseph M, Daniel M. Pulmonary alveolar proteinosis.Mon journal of the Association of Physicians[Internet]. 2018 [consultado 04 Ene 2024]; 111(3):185-186. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK482308/

  9. Andrew B, Rishi P. Pulmonary alveolar proteinosisin children. Breather journals [Internet]. 2020[consultado 04 Ene 2024]; 16(2): 1-15. Disponibleen: https://breathe.ersjournals.com/content/breathe/16/2/200001.full.pdf

  10. Griese M, Brasch F, Aldana V, Cabrera M, Goelnitz U,Ikonen E, et al. Respiratory disease in Niemann-Picktype C2 is caused by pulmonary alveolar proteinosis.Clinical Genetics [Internet]. 2010 [consultado 04Ene 2024]; 77(22): 119-130. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1399-0004.2009.01325.x

  11. Yoshida M, Ikegami M, Reed J, Chroneos Z, WhitsettJ. GM-CSF regulates protein and lipid catabolism byalveolar macrophages. American Physiology Society[Internet]. 2001 [consultado 04 Ene 2024]; 280(3):379-86. Disponible en: https://journals.physiology.org/doi/full/10.1152/ajplung.2001.280.3.L379

  12. Kanji U, David C, Takashi Y, Pierre-Yves B, ShuichiA, Margaret K, et al. GM-CSF autoantibodies andneutrophil dysfunction in pulmonary alveolar proteinosis.The New England journal of medicine[Internet]. 2007 [consultado 04 Ene 2024]; 356(6):567-579. Disponible en: https://www.nejm.org/doi/full/10.1056/NEJMoa062505

  13. Takayuki K, Naohiko T, Junichi W, Uchida, ShiroK, Yoshitugu Y, et al. Idiopathic pulmonary alveolarproteinosis as an autoimmune disease withneutralizing antibody against granulocyte/macrophagecolony-stimulating factor. J Exp Med[Internet]. 1999 [consultado 05 Ene 2024]; 190(6):875-880. Disponible en: https://rupress.org/jem/article/190/6/875/29921/Idiopathic-Pulmonary-Alveolar-Proteinosis-as-an

  14. Takuji S, Takuro S, Lisa R, Brenna C, Robert E, MaurizioL, et al. Hereditary pulmonary alveolar proteinosis:pathogenesis, presentation, diagnosis, andtherapy. AJRCMB jorunals [Internet]. 2010 [consultado05 Ene 2024]; 182(10): 1292-1304. Disponibleen: https://www.atsjournals.org/doi/10.1164/rccm.201002-0271OC

  15. Kanji U, Koh N, Brenna C, Claudia C, Takuji S, TakuroS, et al. Standardized serum GM-CSF autoantibodytesting for the routine clinical diagnosis of autoimmunepulmonary alveolar proteinosis. Journal ofimmunological methods [Internet]. 2014 [consultado08 Ene 2024]; 402(2): 57-70. Disponible en:http://dx.doi.org/10.1016/j.jim.2013.11.011

  16. Pierre G, Benoit W, Stefan N, Jonas Y, Stavros A,Christophe H, et al. Efficacy of Whole Lung Lavagein Pulmonary Alveolar Proteinosis: A MulticenterInternational Study of GELF. Respiration[Internet]. 2017 [consultado 08 Ene 2024]; 93(3):198-206. Disponible en: https://karger.com/res/article/93/3/198/294908/Efficacy-of-Whole-Lung-Lavage-in-Pulmonary

  17. Ilaria C, Maurizio L, Matthias G, Carmine T, GiuseppeR. A global survey on Whole Lung Lavage inPulmonary Alveolar Proteinosis. Chest Journal [Internet].2016 [consultado 08 Ene 2024]; 150(1): 251-253. Disponible en: https://journal.chestnet.org/article/S0012-3692(16)49002-1/fulltext

  18. Gaohong S, Peng C, Yanqiu W, Jiaojiao C, Xiaolei C,Hui-Lan Z. Better approach for autoimmune pulmonaryalveolar proteinosis treatment: inhaled or subcutaneousgranulocyte-macrophage colony-stimulatingfactor: a meta-analyses. BMC Respiratoryresearch [Internet]. 2018 [consultado 08 Ene 2024];19(1): 163. Disponible en: https://respiratory research.biomedcentral.com/articles/10.1186/s12931-018-0862-4

  19. Bruce C, Koh N, Francesco B, Ilaria C, MatthiasG, John H, et al. Pulmonary alveolar proteinosis.Nature reviews disease primers [Internet]. 2019[consultado 10 Ene 2024]; 5(16): 1-17. Disponibleen: https://www.nature.com/articles/s41572-019-0066-3

  20. Shibata Y, Berclaz P, Chroneos Z, Yoshida M, WhitsettJ, Trapnell B. GM-CSF regulates alveolar macrophagedifferentiation and innate immunity in thelung through PU.1. A Cell Press Journal: Inmunity[Internet]. 2001 [consultado 10 Ene 2024]; 15(4):557-567. Disponible en: https://doi.org/10.1016/S1074-7613(01)00218-7




2020     |     www.medigraphic.com